| Primary |
| Product Used For Unknown Indication |
29.2% |
| Drug Use For Unknown Indication |
23.6% |
| Pain |
13.9% |
| Hepatitis C |
8.3% |
| Back Pain |
4.2% |
| Fibromyalgia |
4.2% |
| Breakthrough Pain |
2.8% |
| Arthropathy |
1.4% |
| Asthma |
1.4% |
| Convulsion |
1.4% |
| Dysmenorrhoea |
1.4% |
| Intervertebral Disc Degeneration |
1.4% |
| Migraine |
1.4% |
| Osteoarthritis |
1.4% |
| Panic Attack |
1.4% |
| Procedural Pain |
1.4% |
| Road Traffic Accident |
1.4% |
|
| Drug Ineffective |
29.0% |
| Pain |
6.5% |
| Pharmaceutical Product Complaint |
6.5% |
| Vomiting |
6.5% |
| Anaemia |
3.2% |
| Constipation |
3.2% |
| Dizziness |
3.2% |
| Epistaxis |
3.2% |
| Haemorrhage |
3.2% |
| Headache |
3.2% |
| Hepatic Enzyme Increased |
3.2% |
| Mental Impairment |
3.2% |
| Pain In Extremity |
3.2% |
| Product Packaging Quantity Issue |
3.2% |
| Pruritus |
3.2% |
| Scoliosis |
3.2% |
| Tinnitus |
3.2% |
| Tongue Blistering |
3.2% |
| Tremor |
3.2% |
| Unevaluable Event |
3.2% |
|
| Secondary |
| Pain |
27.3% |
| Drug Use For Unknown Indication |
9.7% |
| Confusional State |
7.9% |
| Fall |
7.9% |
| Pelvic Pain |
7.9% |
| Ill-defined Disorder |
5.7% |
| Arthralgia |
4.0% |
| Headache |
3.5% |
| Product Used For Unknown Indication |
3.5% |
| Fibromyalgia |
3.1% |
| Gingival Pain |
3.1% |
| Back Pain |
2.6% |
| Breakthrough Pain |
2.6% |
| Convulsion |
2.6% |
| Anxiety |
1.8% |
| Back Injury |
1.8% |
| Hepatitis C |
1.8% |
| Migraine |
1.3% |
| Depression |
0.9% |
| Hypercholesterolaemia |
0.9% |
|
| Abdominal Distension |
15.0% |
| Rhabdomyolysis |
10.0% |
| Weight Decreased |
10.0% |
| Drug Ineffective |
7.5% |
| Haematemesis |
7.5% |
| Oedema |
7.5% |
| Pain In Extremity |
5.0% |
| Tooth Loss |
5.0% |
| Vision Blurred |
5.0% |
| Drug Dependence |
2.5% |
| Hepatic Enzyme Increased |
2.5% |
| Hypercoagulation |
2.5% |
| Hyponatraemia |
2.5% |
| Influenza |
2.5% |
| Inhibitory Drug Interaction |
2.5% |
| Medication Error |
2.5% |
| Nausea |
2.5% |
| Pain |
2.5% |
| Peptic Ulcer Perforation |
2.5% |
| Rectal Haemorrhage |
2.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
23.4% |
| Pain |
14.3% |
| Depression |
8.2% |
| Metastases To Bone |
6.0% |
| Hypertension |
5.5% |
| Drug Use For Unknown Indication |
5.1% |
| Anxiety |
3.9% |
| Hepatitis C |
3.5% |
| Rheumatoid Arthritis |
3.5% |
| Arthritis |
3.2% |
| Breast Cancer |
3.2% |
| Insomnia |
3.0% |
| Multiple Sclerosis |
2.8% |
| Back Pain |
2.5% |
| Diabetes Mellitus |
2.3% |
| Bone Pain |
2.2% |
| Prostate Cancer |
2.0% |
| Smoking Cessation Therapy |
2.0% |
| Sarcoidosis |
1.9% |
| Fibromyalgia |
1.7% |
|
| Weight Decreased |
18.8% |
| Vomiting |
11.3% |
| Pain |
8.5% |
| Type 2 Diabetes Mellitus |
6.6% |
| Weight Increased |
6.1% |
| Pulmonary Embolism |
4.7% |
| Somnolence |
4.7% |
| Wound Infection Staphylococcal |
4.2% |
| Syncope |
3.8% |
| White Blood Cell Count Decreased |
3.8% |
| Oedema Peripheral |
3.3% |
| Pneumonia |
3.3% |
| Urinary Tract Infection |
3.3% |
| Headache |
2.8% |
| Myocardial Ischaemia |
2.8% |
| Suicidal Ideation |
2.8% |
| Nausea |
2.3% |
| Pain In Extremity |
2.3% |
| Rash |
2.3% |
| Toothache |
2.3% |
|
